Reuters logo
BRIEF-Immunocellular Therapeutics and Memgen announce letter of intent for potential joint immuno-oncology collaboration
March 23, 2017 / 10:19 AM / 8 months ago

BRIEF-Immunocellular Therapeutics and Memgen announce letter of intent for potential joint immuno-oncology collaboration

March 23 (Reuters) - Immunocellular Therapeutics Ltd

* Immunocellular Therapeutics and Memgen announce letter of intent for potential joint immuno-oncology collaboration

* Immunocellular Therapeutics - LoI is to exclusively negotiate terms to possibly establish an immuno-oncology strategic collaboration

* Immunocellular Therapeutics - collaboration focused on conducting clinical trials combining cos’ respective cancer immunotherapy product candidates Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below